Gilead Sciences Is Acquiring Arcellx and Partnered Multiple Myeloma Drug in $7.8B Deal
Gilead Sciences and Arcellx have been collaborating on the a number of myeloma cell remedy anito-cel since 2022. This remedy ...
Gilead Sciences and Arcellx have been collaborating on the a number of myeloma cell remedy anito-cel since 2022. This remedy ...
Individuals with multiple long-term conditions are two and a half times more likely to die following COVID-19 infection than others. ...
Though some of Africa’s biggest mpox hot spots continue to see downward trends, fresh spikes are occurring in other countries ...
The human papillomavirus (HPV) can cause six types of cancer. It's responsible for almost all cervical cancer cases. HPV now ...
While some health issues are visible to the outside world, many people face chronic conditions that don't have externally visible ...
Antibodies that bind to two targets are an established way of treating the blood cancer multiple myeloma. Aiming to top ...
Regeneron Pharmaceuticals is expanding its cancer drug lineup with FDA approval of a bispecific antibody it developed for multiple myeloma, ...
A new study offers insight into what is happening in our brains when our working memory must use its limited ...
RNA-based medicines are one of the most promising ways to fight human disease, as demonstrated by the recent successes of ...
Credit: Pixabay/CC0 Public Domain People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.